top of page

IVDR Transition Period Extension Application: EBS and ÜTS Steps

The IVDR transition extension rests on Regulation (EU) 2024/1860 and requires a two-stage application. Deadlines by class, and the scenarios for devices with an EC certificate and self-declared devices.

The ÜTS record of your IVDD in vitro diagnostic device is about to drop because of its "registered period", and your manufacturer has written to you that they have signed a contract with a notified body. The natural reflex is to upload the contract to ÜTS and try to update the document. This route is closed: an update application made in ÜTS is rejected without a permission obtained beforehand through the Electronic Application System (EBS), and the text of a contract with a notified body is not accepted as evidence.

This page opens up the two-legged structure of the IVDR transition period extension: until which date each device may stay on the market, what the manufacturer must have in hand, which documents are submitted to EBS and with what minimum content, and how an extension found appropriate is defined in ÜTS. The sources are the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz) and Regulation (EU) 2024/1860, on which the Manual relies.

The extension is not a right but the result of a two-stage application

Article 48(5) of the Manual sets the order firmly: for firms to be able to benefit from the IVDR transitional provisions for their devices under paragraphs 3 and 4 of this article, they must first apply through EBS under Article 49 of the Manual, and if this application is found suitable by the Agency, they must make the device and/or document registration/update applications in ÜTS for the relevant devices and linked documents under Article 50 of the Manual.

Article 50(2)(a) of the Manual writes the counterpart of this: if no application is made in EBS under Article 49 of the Manual and the Agency does not allow the extension of the period, the document registration/update application to be made under this article is rejected. Article 50(3)(a) repeats the same result for the declaration of conformity.

Article 49(1) of the Manual also states that the application is made through EBS with a petition. That is, the process begins not in ÜTS but with an EBS file opened with a petition.

The basis is Regulation (EU) 2024/1860 and its national reflection

Article 48(1) of the Manual gives the basis by name: the Regulation "amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the information obligation in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices". The same paragraph says that this Regulation entered into force by being published in the Official Journal of the EU on 09.07.2024.

The Regulation's own particulars differ from the date the Manual gives: the title of the text published in the Official Journal of the European Union describes the Regulation as dated 13 June 2024, and 9 July 2024 is its publication date. The Manual refers to the Regulation by its publication date.

Article 48(2) of the Manual carries an inconsistency in describing the national reflection: for the "Regulation Amending the In Vitro Diagnostic Medical Device Regulation" ("İn Vitro Tanı Amaçlı Tıbbi Cihaz Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik"), stated to have been published in parallel with the 2024 Regulation, the Official Gazette No. 32151 of 2/4/2023 is given. The Manual does not reconcile these two dates. The Turkish counterpart of the part of the same Regulation concerning the notification of supply interruption, on the other hand, is observable: Article 10/A(1)(a) of the Medical Device Regulation, added by the Official Gazette No. 32635 of 17/8/2024, regulates the manufacturer's notification to the Agency and to the parties it directly supplies of a foreseen supply interruption; point (b) of the same paragraph says that this information is provided at least six months before the interruption, except in exceptional circumstances.

The final date for devices with old certificates is 31.12.2027

Article 48(3) of the Manual says that, provided that the conditions set out in the relevant Regulation are met, devices placed on the market under the IVDD as Annex-2 List-A, Annex-2 List-B and Self-Testing Devices may be made available on the market or put into service until 31.12.2027.

The first screening for this group is made by Article 49(2)(a) of the Manual: no extension applies to devices covered by an EC certificate issued by a competent notified body under the IVDD whose document expiry date is before 26.05.2022. A file that arrives with an IVDD certificate that expired before this date is not eligible for an extension, even if every other document has been completed.

For IVDs placed on the market on the manufacturer's own declaration, the final date varies by class

Article 48(4) of the Manual defines the second group: devices for which the conformity assessment procedure under the IVDD did not require the involvement of a notified body, for which a declaration of conformity was drawn up before 26 May 2022, and for which the conformity assessment procedure under the IVDR requires the involvement of a notified body. For these, the dates differ according to risk class.

Point (a) of the same paragraph gives the date 31.12.2027 for devices to be classified under the IVDR as Class D, Self-Testing Device (Class D), Near-Patient Testing Device (Class D) and Companion Diagnostic Device (Class D); point (b) gives 31.12.2028 for Class C, Self-Testing Device (Class C), Near-Patient Testing Device (Class C) and Companion Diagnostic Device (Class C); and point (c) gives 31.12.2029 for Class B, Near-Patient Testing Device (Class B) and Class A Sterile.

The point to watch is this: the class taken as the basis here is not the device's position under the IVDD but the class under which it will be classified under the IVDR. Even if your device was being placed on the market on your own declaration under the IVDD, the IVDR class determines the date of the extension.

Application scenarios and the period granted for devices with EC certificates

Article 49(2) of the Manual defines five separate scenarios for devices with old certificates, and in each of them a different set of evidence is requested.

  • Contract signed before the document expiry date: Point (b) of the same paragraph says that, for EC certificates that are valid on and after 26.05.2022 and whose document expiry date is before 09.07.2024, if the manufacturer applied to a notified body designated under the IVDR and signed a contract before the document expiry date, the Manufacturer's Declaration, the NB Confirmation Letter and the document showing that the surveillance responsibility has been taken over until 26.09.2025 are requested.

  • Contract signed after the document expiry date: Point (c) of the same paragraph looks, as the third document, instead of the surveillance document, for the permission document obtained from the Agency under Article 56(1) of the IVDR or the document issued by the Agency under Article 91(1) of the IVDR.

  • No application to a notified body at all: Point (ç) of the same paragraph requires, for certificates expiring on or after 09.07.2024 where no application has been made to a notified body under the IVDR, the Manufacturer's Declaration and the surveillance document valid until 26.05.2025.

  • Only an application made: Point (d) of the same paragraph looks for the Manufacturer's Declaration, the NB Acceptance Document and the surveillance document valid until 26.09.2025, if the application was made before 26.05.2025.

  • Application and contract both completed: Point (e) of the same paragraph requires, where the application was made before 26.05.2025 and the contract before 26.09.2025, the Manufacturer's Declaration, the NB Confirmation Letter and the surveillance document valid until 26.09.2025.

The period granted also depends on the scenario. Point (f) of the same paragraph says that, in applications found appropriate under point (b) or (c), the validity date of the EC certificate will be extended until 31.12.2027; point (g) says until 26.05.2025 under point (ç); point (ğ) until 26.09.2025 under point (d); and point (h) until 31.12.2027 under point (e). Point (ı) of the same paragraph states that, in order for these approved actions to be defined in ÜTS, an application must be made in ÜTS under Article 50 of the Manual.

There is a technical detail common to all application types: when logging in to EBS, "Notice No. 2023/KK-1 Extension Application" ("2023/KK-1 Sayılı Süre Uzatım Başvurusu") is selected as the application document type, and the application is made without physical paperwork.

There are two scenarios for devices placed on the market on their own declaration

Article 49(3)(a) of the Manual defines the first scenario: provided that the manufacturer applies to a notified body designated under the IVDR before 26.05.2025 for devices in the Class D group, before 26.05.2026 for devices in the Class C group, and before 26.05.2027 for devices in the Class B and Class A Sterile group, the Manufacturer's Declaration and the NB Acceptance Document are submitted.

Point (b) of the same paragraph is the second scenario: if the contract is made before 26.09.2025 for the Class D group, before 26.09.2026 for the Class C group, and before 26.09.2027 for the Class B and Class A Sterile group, the Manufacturer's Declaration and the NB Confirmation Letter are submitted.

The results differ as well. Point (c) of the same paragraph says that, in applications found appropriate under point (a), the period during which the devices stay registered in ÜTS and the validity of the declaration of conformity are extended until 26.09.2025, 26.09.2026 and 26.09.2027 respectively. Point (ç) of the same paragraph states that, in applications found appropriate under point (b), these periods are extended until 31.12.2027, 31.12.2028 or 31.12.2029, according to the risk class of the device.

The management rule that follows from this is clear: having merely applied to a notified body buys you a short period; the long period is opened by a signed contract.

The minimum content of the Manufacturer's Declaration is defined

Article 49(4) of the Manual lists the minimum matters that must be in the declaration to be prepared by the manufacturer:

  • Conformity continues: Point (a) of the same paragraph asks for a statement that the device continues to comply with the IVDD.

  • No change: Point (b) looks for a statement that there is no significant change in the design and intended purpose of the device.

  • No unacceptable risk: Point (c) asks for a statement that the device does not present an unacceptable risk to the health or safety of patients, users or other persons or to other aspects of the protection of public health.

  • Quality management system: Point (ç) looks for a statement that a quality management system will be put in place, or has been put in place, in accordance with Article 10(8) of the IVDR, not later than 26.05.2025.

  • Application to a notified body: Point (d) asks for a statement that a formal application has been made in accordance with the first subparagraph of Section 4.3 of IVDR Annex VII, not later than the dates determined according to the risk group of the device, and requires that the declaration also contain details such as the four-digit identification number of the notified body, the number of the EC certificate covered by the application and the devices covered by the application.

  • Written agreement: Point (e) looks for a statement that a written agreement has been signed or will be signed in accordance with the second subparagraph of Section 4.3 of IVDR Annex VII, not later than the dates determined according to the risk group, and the details of the agreement.

  • Contact details for confirmation: Point (f) asks for the contact details, including the e-mail address, of the authorised person of the manufacturer firm that issued the declaration, so that the validity of the declaration can be confirmed.

The last item alone causes many applications to fall. Article 49(8) of the Manual makes it mandatory that the confirmation e-mail details of the manufacturer are complete in the manufacturer's declaration and/or in the application petition. Paragraph 16 of the same article says that if the evidence documents are not confirmed by the manufacturer or the notified body, or if the party concerned reports that the document is not current or valid, the application will have a negative outcome.

The NB Confirmation Letter and the NB Acceptance Document are not the same document

The two documents are often sent in place of one another; the Manual defines them in separate paragraphs.

Article 49(5) of the Manual defines the NB Confirmation Letter. Point (a) of the same paragraph looks for a statement that the manufacturer's conformity assessment application has been received; point (b) a statement that a written agreement has been signed after the application in accordance with the second subparagraph of Section 4.3 of IVDR Annex VII; point (c) an unambiguous listing of the devices covered by the agreement that will benefit from the extension; point (ç) the EC certificate information covered by the agreement; and point (d) the contact details, including the e-mail address, of the notified body official who issued the document, and states that, if this information is absent, the confirmation e-mail will be sent to the e-mail address of the notified body defined in NANDO.

Article 49(6) of the Manual defines the NB Acceptance Document. The difference appears in the first point: point (a) asks for a statement that the application has been received and accepted in accordance with the first subparagraph of Section 4.3 of IVDR Annex VII, including the application date and the application acceptance date. The Confirmation Letter documents a signed agreement, while the Acceptance Document documents an accepted application.

Article 49(14) of the Manual also closes a misunderstanding: attaching the text of the agreement made with the notified body and/or inspection plans to the application in place of the document mentioned in paragraph 5 is not accepted.

The petition, the single-document rule and the cases that lead to a negative outcome

Article 49(7) of the Manual says that applications made to the Agency under this article without a petition will not be accepted. The petition must state the document for which the transition period is requested (the EC Certificate for applications under paragraph 2, the Declaration of Conformity for applications under paragraph 3) and, if any, the devices excluded from the scope of the document.

Paragraph 17 of the same article limits the scope: the applicant firm can request a transition period for only a single document in an application made under this article; if there is more than one document in the petition for which assessment is requested, the application is not taken into assessment and has a negative outcome. If your portfolio has five EC certificates, five separate EBS applications are opened.

The other grounds for a negative outcome are listed as well. Paragraph 9 of the same article requires that there be no inconsistency among the Manufacturer's Declaration, the NB Confirmation Letter, the NB Acceptance Document and any other documents; paragraph 10 requires, where there is an inconsistency between the manufacturer information in the evidence documents and the manufacturer information in the document for which the transition period is requested, that additional evidence documents eliminating this inconsistency also be attached; paragraph 11 requires that Turkish translations, certified by a sworn translator, of all documents whose originals are in a foreign language be attached; paragraph 12 makes it mandatory, in applications under paragraph 3, to attach to the file the Declaration of Conformity covering the devices; and paragraph 15 states that an application made in violation of the provisions of the article, or with evidence documents attached incompletely or incorrectly, or with documents different from those requested, will have a negative outcome.

Article 49(19) of the Manual encourages the documents mentioned in paragraphs 4, 5 and 6 to be in the form of the templates published by the European Commission.

An expired document is placed inside the EBS file

The situation firms hesitate over most is when the document for which an extension is requested has already expired. Article 49(13) of the Manual separates these two cases.

Point (a) of the same paragraph says that, if the current validity period of the EC Certificate or the Declaration of Conformity has not expired, before applying under paragraph 2 or 3 the most current version of the document concerned must be brought to registered status in ÜTS under Articles 8 or 9, or 12 to 13 and 39 of the Manual.

Point (b) of the same paragraph states that, if the validity period of the document has expired, the EBS application must first be made by attaching the most current version of this document to the application file (together with its Turkish translation certified by a sworn translator, where necessary). In both cases, after the application has a positive outcome, an application is made in ÜTS with the most current version of the document concerned under Article 50 of the Manual.

A common assumption needs correcting here: registering an expired document directly in ÜTS and attaching a manufacturer's declaration to it is not a route defined in the Manual. The Manual puts the expired document inside the EBS file and ties the ÜTS step to the Agency's Confirmation Letter.

The ÜTS step: the 2023/KK-1 field and the evidence documents

Article 50(2)(b) of the Manual says that, when "98/79/EC" is selected in the "Regulation It Belongs To" ("Ait Olduğu Yönetmelik") field on the ÜTS "Update Document" ("Belge Güncelle") screen for an EC certificate whose extension has been found appropriate, the field "Is it a Document Registration/Update Notification Application under Notice No. 2023/KK-1?" ("2023/KK-1 Sayılı Duyuru Kapsamında Belge Kayıt/Güncelleme Bildirimi Başvurusu mu?") appears on the screen. Point (c) of the same paragraph states that "Yes" must be selected in this field, whereupon the mandatory document field called "Evidence Documents for IVDR Transition Period Extension" ("IVDR Geçiş Süresi Uzatımı İçin Kanıt Dokümanlar") opens.

Point (ç) of the same paragraph lists what is uploaded to this field: the Confirmation Letter ("Teyit Yazısı") stating that the Agency has allowed the extension, and all the declarations and documents in the application made under Article 49 of the Manual, in a single file and complete with all pages. Point (d) of the same paragraph says that no apostille or notarisation is required for these documents, but the Turkish translations of documents whose originals are in a foreign language must be certified by a sworn translator.

The date field is fixed too. Point (e) of the same paragraph says that the original expiry date of the EC certificate is entered in the "Document Expiry Date" ("Belge Bitiş Tarihi") field; point (ğ) says that, if the application is found appropriate, the expiry date will be updated by the Agency to the date stated in the Confirmation Letter. Point (g) of the same paragraph says that, at the application stage, "Document Application under Notice No. 2023/KK-1" ("2023/KK-1 Sayılı Duyuru Kapsamında Belge Başvurusu") is selected as the "Application Type", and that there is no need to send the uploaded documents physically to the Agency. Article 39(8) of the Manual ties this application type to the list of document applications.

Article 50(3) of the Manual repeats the same steps where an extension is to be defined for a declaration of conformity; point (e) of the same paragraph says that the original expiry date is entered in the "Document Expiry Date" field if the declaration is Limited-Term, and that the field is left blank if it is Unlimited-Term.

The status of the declaration of conformity requires a separate action

Granting an extension to an EC certificate does not by itself keep the declaration linked to it registered. Article 50(2)(h) of the Manual says that, if the declaration of conformity linked to the devices covered by the EC certificate granted the extension is "Limited-Term" and has a record in ÜTS, a request is created, without creating a document registration/update application, using the "Report Request" ("Talep Bildir") screen and selecting "MDR/IVDR Transition Period Extension" ("MDR/IVDR Süre Uzatımı") as the "Request Field". Sub-point (2) of the same point makes it mandatory to enter the ÜTS Document Number of the declaration of conformity concerned in this request, and holds the applicant firm responsible for erroneous operations that may arise if it is not entered.

Sub-point (4) of the same point completes the distinction: these actions are not performed for Unlimited-Term declarations of conformity, that is, those with no "Document Expiry Date"; if such a declaration is not registered in ÜTS, a normal document registration/update application is made under the provisions of Articles 12 or 13 and 39 of the Manual.

If the declaration has no record in ÜTS at all, the route differs again. Sub-point (1) of point (ı) of the same paragraph says that, for the declaration, "Is it unlimited-term?" is selected "Yes" on the "Document Registration/Update" screen and no "Document Expiry Date" is entered for the document; sub-point (2) says that, after the application is created, a request is opened from the "MDR/IVDR Transition Period Extension" request field to be assessed under "Notice No. 2024/KK-3", and that entering the Document Application Number in this request is mandatory.

Article 49(18) of the Manual also lays down a general rule: requests to be created through ÜTS concerning the processes under this article must be created by selecting the "MDR/IVDR Transition Period Extension" request field, and the transaction tracking number of the EBS application for which information is requested must be added to the request.

As of today, which dates have passed and which lie ahead

Some of the dates written in the Manual lie in the past as of today. The date 26.05.2025 given for the manufacturer to put its quality management system in place, the dates 26.05.2025 given for the application to a notified body and 26.09.2025 given for the contract in the Class D group, and the date 26.05.2026 given for the application in the Class C group have passed. The date 26.09.2026 given for the contract in the Class C group, the date 26.05.2027 given for the application in the Class B and Class A Sterile group, and the date 26.09.2027 given for the contract have not yet arrived.

The final dates for staying on the market, 31.12.2027, 31.12.2028 and 31.12.2029, also lie ahead. The conclusion that follows is this: if a condition date has passed, meeting that condition afterwards does not bring the extension back; the scenarios in Article 49 of the Manual look at the date up to which the condition was met. Determining which scenario your device falls into is the work to be done before preparing the file. It would be sensible to confirm the current state of these dates and the Agency's practice from the Agency, through the latest announcements.

What we do in an extension application, and what we cannot do

Within medical device ÜTS registration consultancy, MEDx Kurumsal Danışmanlık carries out the file and record side of the IVDR transition period extension. The concrete outputs are these:

  • Scenario determination: For each EC certificate and declaration of conformity, determining, with reasons given date by date, which point of paragraphs 2 and 3 of Article 49 of the Manual applies.

  • Evidence document checklist: Checking the Manufacturer's Declaration, the NB Confirmation Letter or the NB Acceptance Document against the minimum matters in paragraphs 4, 5 and 6 of Article 49 of the Manual, and listing the missing items in a form that can be passed to the manufacturer.

  • Consistency scan: Detecting, before the application, inconsistencies between documents and between manufacturer details under paragraphs 9 and 10 of Article 49 of the Manual.

  • EBS file design: Preparing the petition, the division of applications in line with the single-document rule, and the sworn translation set.

  • ÜTS step: Filling in the fields in Article 50 of the Manual, uploading the evidence documents as a single file and, where necessary, opening the "MDR/IVDR Transition Period Extension" request.

What we cannot do is clear as well. The Manufacturer's Declaration is issued by the manufacturer; Article 49(4) of the Manual ties the declaration to the manufacturer, and confirmation of the declaration is made through the e-mail of the manufacturer's authorised person. The NB Confirmation Letter and the NB Acceptance Document are issued by the notified body; the consultant cannot obtain these documents, and can only check whether their content meets the minimum matters. The application to the notified body and the contract are a matter between the manufacturer and the notified body. The quality management system is also the manufacturer's obligation. The outcome of the application is at the Agency's discretion, and no commitment on the outcome is given for any application.

Our way of working is this: your firm defines a user authorisation for us from its own ÜTS firm page, we create the ÜTS records with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorisation, and the person who electronically signs the EBS and ÜTS applications remains your firm's signatory.

Tıbbi Cihaz ÜTS Kayıt Danışmanlığı

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara